Rapt Therapeutics, Inc.

This study tested an experimental daily pill called RPT193 in 229 adults with moderate-to-severe atopic dermatitis (eczema) that didn't improve with topical creams. The goal was to see if the pill could reduce eczema severity over 16 weeks. The trial was ended early, so results a…

This study tested an experimental drug called RPT193 in 38 adults with moderate-to-severe asthma that was not fully controlled by their usual inhalers. The goal was to see if the drug could prevent asthma attacks and improve lung function. The study was stopped early, so results …